Skip to search formSkip to main contentSkip to account menu

Pyridoxamine

Known as: 3-Pyridinemethanol, 4-(aminomethyl)-5-hydroxy-6-methyl-, Pyridoxamine [Chemical/Ingredient] 
The 4-aminomethyl form of VITAMIN B 6. During transamination of amino acids, PYRIDOXAL PHOSPHATE is transiently converted into pyridoxamine phosphate… 
National Institutes of Health

Related topics

Related topics

18 relations
In BloodProcess of secretionPyridoxal PhosphateVitamin B6

Broader (2)

PicolineVitamin B Complex

Narrower (4)

bromoacetylpyridoxaminebromoacetylpyridoxamine phosphatepyridoxamine dihydrochloridepyridoxamine phosphate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment
Diabetes mellitus is an important and prevalent risk factor for congestive heart failure. Diabetic cardiomyopathy has been… 
Review
2011
Review
2011
Oxidative stress and the etiology of insulin resistance and type 2 diabetes.
Review
2009
Review
2009
Hyperglycemia and glycation in diabetic complications.
Diabetes mellitus is a multifactorial disease, classically influenced by genetic determinants of individual susceptibility and by… 
Highly Cited
2007
Highly Cited
2007
Effects of Pyridoxamine in Combined Phase 2 Studies of Patients with Type 1 and Type 2 Diabetes and Overt Nephropathy
Background/Aims: Treatments of diabetic nephropathy (DN) delay the onset of end-stage renal disease. We report the results of… 
Review
2006
Review
2006
Protein carbonylation, cellular dysfunction, and disease progression
Carbonylation of proteins is an irreversible oxidative damage, often leading to a loss of protein function, which is considered a… 
Review
2004
Review
2004
Protein Glycation: A Firm Link to Endothelial Cell Dysfunction
The advanced glycation end products (AGEs) are a heterogeneous class of molecules, including the following main subgroups: bis… 
Highly Cited
2002
Highly Cited
2002
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.
BACKGROUND Nonenzymatic reactions between sugars or lipids and protein and formation of advanced glycation and lipoxidation end… 
Highly Cited
2002
Highly Cited
2002
The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.
We examined the ability of pyridoxamine (PM), an inhibitor of formation of advanced glycation end products (AGEs) and… 
Review
2000
Review
2000
Glycoxidation and lipoxidation in atherogenesis.
Highly Cited
1984
Highly Cited
1984
Mechanism of action of aspartate aminotransferase proposed on the basis of its spatial structure.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)